Accessibility Statement

Publications | July 11, 2019

IPR For Biosimilars: Examining The Benefits And Drawbacks

Biosimilar Development

Author

John L. Abramic

Overview

Steptoe partner John Abramic authored an article titled "IPR For Biosimilars: Examining The Benefits And Drawbacks" for Biosimilar Development. The article, published July 11, examines the use of inter partes review (IPR) proceedings for matters involving biosimilars.

Professionals

John L. Abramic
John Abramic, managing partner of the Chicago office, is a seasoned litigator who represents clients in complex intellectual property disputes. He serves as lead counsel in intellectual property...

Partner

Patent Litigation, Post-Grant Proceedings, Trade Secrets, Patent

Practices

Patent Litigation

Patent

Press Releases Steptoe Welcomes Allison Jones to Expanding Transactions Practice, Augmenting Real Estate and Energy Capabilities October 15, 2025 Press Releases Steptoe Recognized on 2025 National Women's Law Center Pro Bono Honor Roll October 10, 2025 Webinars Ratemaking 101 October 16, 2025
Press Releases Steptoe Receives Seven Practice and Ten Individual Rankings in Legal 500 UK 2026 October 1, 2025 Press Releases Steptoe Secures Major Victory for ExxonMobil in Venezuela Asset Seizure Case October 1, 2025 Press Releases The Anti-Corruption Report Quotes Yousuf Aftab on Compliance Risks and Human Rights October 1, 2025 Press Releases Yi Han Dulkeith Joins Steptoe, Strengthens Life Sciences Patent Bench in New York September 17, 2025 Press Releases Lisa Zarlenga Named Chair-Elect of ABA Section of Taxation September 10, 2025 Press Releases Michelle Kallen Named a 2025 DC Rising Star by the National Law Journal September 9, 2025 Press Releases Steptoe Rises to 23 in The American Lawyer's 2025 Midlevel Associate Satisfaction Survey September 8, 2025 Press Releases Steptoe Provides Pro Bono Counsel to Help.Fun in Launch of Social Impact Coins September 4, 2025 Press Releases Compliance Innovator and Former In-House Counsel Matt Galvin Joins Steptoe as a Partner in the Investigations, White-Collar and Compliance Group September 3, 2025

View More